<DOC>
	<DOCNO>NCT02933333</DOCNO>
	<brief_summary>The purpose study explore effect G-CSF combination GM-CSF prevention treatment infection child malignant tumor .</brief_summary>
	<brief_title>G-CSF Alone Combination With GM-CSF Prevention Treatment Infection Children With Malignant Tumor</brief_title>
	<detailed_description>G-CSF Alone Combination With GM-CSF Prevention Treatment Infection Children With Malignant Tumor .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Hepatoblastoma</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Patients malignant tumor include acute myeloid leukemia ( AML ) complete remission , acute lymphocytic leukemia ( ALL ) complete remission , stage III IV lymphoma partial remission complete remission , stage III IV neuroblastoma ( NB ) retinoblastoma ( RB ) . Eastern Cooperative Oncology Group performance status â‰¤ 2 . Did receive treatment CSFs two week . Without symptomatic infection normal value Creactive protein procalcitonin . The first time ANC &lt; 1.5*10^9/L chemotherapy . More 24 h last chemotherapy . The function liver normal . Allergic GMCSF drug express Escherichia coli . Patients infection , diabetes primary immunodeficiency . Patients infect hepatitis B , hepatitis C HIV . Patients confirm autoimmune thrombocytopenic purpura .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>